Lates News

According to the AI newsletter of Every Economy, Pacific released a research report on October 31 giving Noucoge (301333.SZ) a "buy" rating. The rating reasons mainly include: 1) Decrease in gross profit margin year-on-year, continuous optimization of management and sales expense ratio; 2) The interest rate reduction cycle has begun + the support policy for innovative drugs has been introduced, and the company has ushered in a rapid development opportunity. (Daily Economic News)